Unveiling drug resistance pathways in high-grade serous ovarian cancer(HGSOC): recent advances and future perspectives

High-Grade Serous Ovarian Carcinoma (HGSOC) represents the most prevalent and lethal subtype of ovarian cancer, with approximately 225,000 new cases reported globally each year and a five-year survival rate of merely 49.1%. The clinical management of HGSOC encounters substantial challenges, primaril...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ruiting Fu, Ruiyue Hu, Wenting Li, Xifang Lv, Hanwei Zhao, Fuxia Li
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2025-04-01
coleção:	Frontiers in Immunology
Assuntos:	high-grade serous ovarian carcinoma (HGSOC) drug resistance mechanisms molecular markers personalized treatment tumor microenvironment
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1556377/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!